BioArctic AB (publ) (FRA:B9A)

BioArctic AB Statistics

Total Valuation

BioArctic AB has a market cap or net worth of EUR 2.36 billion. The enterprise value is 2.19 billion.

Market Cap	2.36B
Enterprise Value	2.19B

Important Dates

The next estimated earnings date is Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	74.24M
Shares Outstanding	n/a
Shares Change (YoY)	+0.60%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	30.83%
Owned by Institutions (%)	47.76%
Float	55.57M

Valuation Ratios

The trailing PE ratio is 26.09 and the forward PE ratio is 62.86.

PE Ratio	26.09
Forward PE	62.86
PS Ratio	13.61
PB Ratio	13.25
P/TBV Ratio	13.25
P/FCF Ratio	24.52
P/OCF Ratio	23.92
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.54, with an EV/FCF ratio of 22.78.

EV / Earnings	24.24
EV / Sales	12.56
EV / EBITDA	18.54
EV / EBIT	18.74
EV / FCF	22.78

Financial Position

The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.02.

Current Ratio	4.18
Quick Ratio	3.14
Debt / Equity	0.02
Debt / EBITDA	0.04
Debt / FCF	0.04
Interest Coverage	40.41

Financial Efficiency

Return on equity (ROE) is 69.23% and return on invested capital (ROIC) is 53.68%.

Return on Equity (ROE)	69.23%
Return on Assets (ROA)	43.46%
Return on Invested Capital (ROIC)	53.68%
Return on Capital Employed (ROCE)	64.18%
Revenue Per Employee	1.42M
Profits Per Employee	741,170
Employee Count	107
Asset Turnover	1.04
Inventory Turnover	n/a

Taxes

In the past 12 months, BioArctic AB has paid 15.64 million in taxes.

Income Tax	15.64M
Effective Tax Rate	14.75%

Stock Price Statistics

The stock price has increased by +62.12% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+62.12%
50-Day Moving Average	26.51
200-Day Moving Average	20.82
Relative Strength Index (RSI)	57.89
Average Volume (20 Days)	98

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioArctic AB had revenue of EUR 173.33 million and earned 90.42 million in profits. Earnings per share was 1.02.

Revenue	173.33M
Gross Profit	168.27M
Operating Income	116.17M
Pretax Income	106.06M
Net Income	90.42M
EBITDA	n/a
EBIT	116.17M
Earnings Per Share (EPS)	1.02

Balance Sheet

The company has 170.22 million in cash and 4.21 million in debt, giving a net cash position of 166.01 million.

Cash & Cash Equivalents	170.22M
Total Debt	4.21M
Net Cash	166.01M
Net Cash Per Share	n/a
Equity (Book Value)	178.12M
Book Value Per Share	2.01
Working Capital	172.59M

Cash Flow

In the last 12 months, operating cash flow was 98.62 million and capital expenditures -2.41 million, giving a free cash flow of 96.22 million.

Operating Cash Flow	98.62M
Capital Expenditures	-2.41M
Free Cash Flow	96.22M
FCF Per Share	n/a

Margins

Gross margin is 97.08%, with operating and profit margins of 67.02% and 52.17%.

Gross Margin	97.08%
Operating Margin	67.02%
Pretax Margin	61.19%
Profit Margin	52.17%
EBITDA Margin	n/a
EBIT Margin	67.02%
FCF Margin	55.51%

Dividends & Yields

BioArctic AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.60%
Shareholder Yield	-0.60%
Earnings Yield	3.83%
FCF Yield	4.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6